|
|
| Quarterly Results |
|
| Ajanta Pharma Ltd | | Industry : Pharmaceuticals - Indian - Formulations | Chairman : Mannalal B Agrawal | | Home : Indian Private | Book Value: 266.5059146 | | BSE Code : 532331 | Market Cap: 27927.68 | | NSE Code : AJANTPHARM | P / E : 36.66 | |
| |
|
|
|
|
|
|
| (Rs in Cr.) |
|
|
| Type | 3Qtr | 2Qtr | 1Qtr | 4Qtr | | Net Sales | 1085.29 | 945.18 | 1014.58 | 848.86 | | Other Income | 13.73 | 52.16 | 31.46 | 36.75 | | Total Income | 1099.02 | 997.34 | 1046.04 | 885.61 | | Total Expenditure | 758.11 | 671.53 | 737.68 | 704.33 | | Operating Profit | 340.91 | 325.81 | 308.36 | 181.28 | | Interest | 2.36 | 2.27 | 0.75 | 1.21 | | Gross Profit | 338.55 | 323.54 | 307.61 | 180.07 | | Depreciation | 33.41 | 33.04 | 32.24 | 32.11 | | Tax | 81.94 | 75.23 | 60.58 | 39.20 | | Deferred Tax | 3.05 | 2.91 | 2.75 | -8.45 | | Reported Profit After Tax | 220.15 | 212.36 | 212.04 | 117.21 |
|
|
|
|
|